Trinity Stock Performance

TRIB
 Stock
  

USD 1.38  0.03  2.13%   

On a scale of 0 to 100, Trinity Bio holds a performance score of 6. The entity has a beta of 0.8412, which indicates possible diversification benefits within a given portfolio. Let's try to break down what Trinity's beta means in this case. As returns on the market increase, Trinity Bio returns are expected to increase less than the market. However, during the bear market, the loss on holding Trinity Bio will be expected to be smaller as well. Although it is vital to follow Trinity Bio ADR current price movements, it is good to be conservative about what you can do with the information regarding equity historical returns. The philosophy towards measuring future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By inspecting Trinity Bio ADR technical indicators, you can presently evaluate if the expected return of 0.25% will be sustainable into the future. Please operates Trinity Bio sortino ratio, skewness, price action indicator, as well as the relationship between the potential upside and rate of daily change to make a quick decision on whether Trinity Bio ADR existing price patterns will revert.
  
Trinity Performance
6 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Trinity Bio ADR are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady forward indicators, Trinity Bio sustained solid returns over the last few months and may actually be approaching a breakup point. ...more

Structure and Payout Changes

Last Split Factor
1:4
Dividend Date
2015-07-01
Ex Dividend Date
2015-06-05
Last Split Date
2005-06-02

Trinity Price Channel

Quick Ratio1.80
Fifty Two Week Low0.8600
Target High Price4.00
Fifty Two Week High3.0500
Target Low Price4.00

Trinity Bio Relative Risk vs. Return Landscape

If you would invest  121.00  in Trinity Bio ADR on May 17, 2022 and sell it today you would earn a total of  17.00  from holding Trinity Bio ADR or generate 14.05% return on investment over 90 days. Trinity Bio ADR is currently generating 0.2521% in daily expected returns and assumes 2.9508% risk (volatility on return distribution) over the 90 days horizon. In different words, 25% of stocks are less volatile than Trinity, and 96% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Daily Expected Return (%)  
       Risk (%)  
Given the investment horizon of 90 days Trinity Bio is expected to generate 2.36 times more return on investment than the market. However, the company is 2.36 times more volatile than its market benchmark. It trades about 0.09 of its potential returns per unit of risk. The DOW is currently generating roughly 0.05 per unit of risk.

Trinity Bio Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Trinity Bio's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Trinity Bio ADR, and traders can use it to determine the average amount a Trinity Bio's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0854

Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small ReturnsTRIB
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative Returns
Estimated Market Risk
 2.95
  actual daily
 
 25 %
of total potential
 
2525
Expected Return
 0.25
  actual daily
 
 4 %
of total potential
 
44
Risk-Adjusted Return
 0.09
  actual daily
 
 6 %
of total potential
 
66
Based on monthly moving average Trinity Bio is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Trinity Bio by adding it to a well-diversified portfolio.

About Trinity Bio Performance

To evaluate Trinity Bio ADR Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Trinity Bio generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Trinity Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Trinity Bio ADR stock market performance in a much more refined way. At Macroaxis, we take it even further. The Macroaxis performance score is an integer between 0 and 100 that represents Trinity's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market in the Americas, Africa, Asia, and Europe. Trinity Biotech plc was incorporated in 1992 and is headquartered in Bray, Ireland. Trinity Bio operates under Pharmaceuticals And Biosciences classification in the United States and is traded on NASDAQ Exchange. It employs 477 people.

Things to note about Trinity Bio ADR

Checking the ongoing alerts about Trinity Bio for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Trinity Bio ADR help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Trinity Bio Alerts

Equity Alerts and Improvement Suggestions

Trinity Bio ADR may become a speculative penny stock
The company reported the previous year's revenue of 86.15 M. Net Loss for the year was (12.95 M) with profit before overhead, payroll, taxes, and interest of 38.08 M.
Additionally, take a look at World Market Map. Note that the Trinity Bio ADR information on this page should be used as a complementary analysis to other Trinity Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Complementary Tools for Trinity Stock analysis

When running Trinity Bio ADR price analysis, check to measure Trinity Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Trinity Bio is operating at the current time. Most of Trinity Bio's value examination focuses on studying past and present price action to predict the probability of Trinity Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Trinity Bio's price. Additionally, you may evaluate how the addition of Trinity Bio to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Is Trinity Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Trinity Bio. If investors know Trinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Trinity Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.77
Market Capitalization
53.7 M
Quarterly Revenue Growth YOY
-0.27
Return On Assets
0.031
Return On Equity
-1.91
The market value of Trinity Bio ADR is measured differently than its book value, which is the value of Trinity that is recorded on the company's balance sheet. Investors also form their own opinion of Trinity Bio's value that differs from its market value or its book value, called intrinsic value, which is Trinity Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Trinity Bio's market value can be influenced by many factors that don't directly affect Trinity Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Trinity Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine Trinity Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Trinity Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.